GET DAILY SIGNALSColgate-Palmolive (CL) vs Procter & Gamble (PG): Weighing Two Defensive Staples Names
Key Takeaways
- CL focuses more narrowly on oral care, personal care, and its Hill's pet nutrition business, while PG maintains a much broader portfolio across beauty, grooming, health care, fabric and home care, and baby, feminine, and family care.
- Both stocks represent low-beta, defensive businesses, yet CL has held up relatively better in recent market conditions, whereas PG has traded near its 52-week lows and below key moving averages in recent months.
- PG currently offers a higher dividend yield of roughly 2.9% compared with CL at roughly 2.3%, reflecting its larger scale and mature cash-flow profile.
- CL growth is increasingly tied to pet nutrition, while PG is relying on productivity savings and a multi-year restructuring that includes eliminating up to 7,000 roles.
- For more information on each ticker's major news and today's price moves, explore the dedicated pages: CL Major News, CL Today's Price Move, PG Major News, and PG Today's Price Move.
- To see how AI is positioning across these and other tickers, explore the Trending AI Robots.
Introduction
Colgate-Palmolive (CL) and Procter & Gamble (PG) rank among the most recognizable consumer staples companies globally, and investors often evaluate them together when seeking defensive, dividend-paying exposure. This comparison matters especially for income-focused investors and risk-conscious traders looking to understand differences in scale, portfolio breadth, and recent momentum between a broad-based giant and a more specialized competitor. Although both operate in household and personal care, their business models, growth drivers, and market positioning have diverged in meaningful ways.
Colgate-Palmolive Overview and Recent Performance
Colgate-Palmolive (CL) derives most of its revenue from oral care, personal care, and home care, with a fast-growing pet nutrition segment centered on the Hill's brand. In its most recent full fiscal year, the company reported net sales of roughly $20.4 billion. Recent weeks have shown relatively resilient share-price behavior, with CL holding up better than many larger staples peers amid a cautious consumer environment. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Sentiment has benefited from steady pricing power and strength in Latin America and Hill's Pet Nutrition, while the exit from private-label pet food and the Prime100 acquisition point to a strategic focus on premium pet nutrition. The stock carries a low beta of approximately 0.32 and trades at a forward price-to-earnings ratio in the low-to-mid 20s.
Procter & Gamble Overview and Recent Performance
Procter & Gamble (PG) operates on a much larger scale, with a market capitalization of roughly $340 billion and a diversified lineup that includes Tide, Pampers, Gillette, Crest, and Olay across multiple categories. Its fiscal year ends in June, unlike CL. Recent market activity has been more difficult: the stock has traded near its 52-week low and below its 50- and 200-day moving averages, pressured by soft category consumption, rising promotional intensity, and value-conscious consumers in North America and Europe. Management has responded with a restructuring that will eliminate up to 7,000 non-manufacturing roles and exit low-margin categories, alongside a Supply Chain 3.0 initiative targeting roughly $1.5 billion in cost savings. PG carries a beta near 0.40 and a dividend yield of roughly 2.9%.
Head-to-Head Comparison
The clearest contrast lies in scale and diversification. PG generates roughly $85 billion in annual revenue and reaches consumers through dozens of category-leading brands, while CL operates at roughly one-quarter of that revenue base and depends more heavily on oral care and a single pet-nutrition platform. This difference shapes their growth drivers: CL leans on international pricing and the Hill's franchise, whereas PG leans on productivity savings and portfolio restructuring. On momentum, CL has shown more consistent relative strength in recent months, while PG has lagged, trading below key technical averages. Risk factors also differ: PG faces execution risk from its restructuring and heightened promotional competition, while CL is exposed to a more concentrated product set and currency volatility in emerging markets. Both remain low-beta defensive names, but their current market positioning points in somewhat different directions.
Tickeron AI Verdict
Based on observable factors such as trend consistency, relative price stability, and the concentration of near-term catalysts, Tickeron's AI would likely favor CL over PG in the current environment. CL has demonstrated steadier trend behavior and clearer support from its pet-nutrition growth engine, whereas PG continues to trade below its longer-term moving averages while navigating a demanding restructuring and promotional backdrop. That said, PG's larger dividend yield and unmatched scale keep it a structurally attractive defensive holding. The assessment is probabilistic rather than definitive, reflecting current momentum and positioning rather than a forecast of guaranteed outcomes.
Using Tickeron AI Tools for Deeper Analysis
One resource I turn to when comparing names like these is Tickeron’s AI Trading Bots. The platform curates a selection of its best-performing automated strategies from a library of hundreds that trade thousands of different tickers. Each bot operates with its own trading style, timeframe, performance record, risk profile, and basket of securities, so the featured lineup surfaces only those strategies aligned with current market conditions. Investors can browse bots by their statistics, historical performance ranges, and the tickers they follow, making it easier to compare data-driven approaches side by side.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
Momentum Indicator for CL turns positive, indicating new upward trend
CL saw its Momentum Indicator move above the 0 level on October 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 68 similar instances where the indicator turned positive. In 34 of the 68 cases, the stock moved higher in the following days. The odds of a move higher are at 50%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for CL just turned positive on October 06, 2026. Looking at past instances where CL's MACD turned positive, the stock continued to rise in 20 of 43 cases over the following month. The odds of a continued upward trend are 47%.
CL moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CL crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 38%.
Following a +2.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where CL advanced for three days, in 143 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.
Bearish Trend Analysis
The 10-day RSI Indicator for CL moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 17 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 22 of 57 cases where CL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 39%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.
CL broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CL entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 28 (best 1 - 100 worst), indicating outstanding price growth. CL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CL's P/B Ratio (311.337) is very high in comparison to the industry average of (21.089). P/E Ratio (36.287) is within average values for comparable stocks, (17.390). Projected Growth (PEG Ratio) (1.577) is also within normal values, averaging (1.518). Dividend Yield (0.023) settles around the average of (0.034) among similar stocks. P/S Ratio (3.331) is also within normal values, averaging (1.931).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a maker of oral, personal, and household products
Industry HouseholdPersonalCare
Advertisement